BICX · BioCorRx Inc. · Documents
$0.24
At close · Oct 20
View the 10-Q filed Aug 14, 2026
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had cash of $21,237 and working capital deficit of $8,231,326. During the six months ended June 30, 2026, the Company used net cash in operating activities of $873,260. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company's ability to continue as a going concern for the next twelve-month period since the date of the financial statements were issued.”View the 10-Q filed Aug 14, 2026
Customer concentration
— top 2 customers 100% of revenue
2 customers — 100% of revenue (three months ended June 30, 2026)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2026 included 100% from two customers of the Company's total revenues.”
2 customers — 99% of revenue (three months ended June 30, 2025)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2025 included 99% from two customers of the Company's total revenues.”
Market Cap
$7.44M
Shares
29.76M
Volume · Oct 20
1000
Avg daily vol (3M)
3256
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-01-30 | — |
Showing 51–51 of 51 filings